Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04873258
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
Sponsor: Richmond Research Institute
View on ClinicalTrials.gov
Summary
A generic screening study to establish structural and/or functional baselines of specific organs.
Official title: Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Volunteers on Clinical Trials Utilising Machine-learning and Bioimpedance Vector Analysis
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2019-09-27
Completion Date
2027-12-31
Last Updated
2025-07-23
Healthy Volunteers
Yes
Conditions
Interventions
DIAGNOSTIC_TEST
Bioimpedence Vector Analysis
Bioimpedence vector analysis
Locations (1)
Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
London, London, United Kingdom